| Final analytical sample | None | Depression only | Cognitive Impairment (CI)6 only | Both | P value |
---|---|---|---|---|---|---|
Number of participants, n (%) | 1956 (100) | 649 (33.2) | 428 (21.9) | 404 (20.7) | 475 (24.3) | Â |
Age, median [IQR] | 80.0 [73.0, 85.0] | 78.0 [72.0, 83.0] | 77.0 [71.0, 83.0] | 82.0 [76.0, 87.0] | 83.0 [77.0, 87.0] |  < 0.001c |
Sex = Male (%) | 967 (49.4) | 400 (61.6) | 192 (44.9) | 193 (47.8) | 182 (38.3) |  < 0.001a |
Education years, median [IQR] | 5.0 [5.0, 8.0] | 8.0 [5.0, 12.0] | 8.0 [5.0, 10.0] | 5.0 [5.0, 8.0] | 5.0 [5.0, 8.0] |  < 0.001c |
Civil status, n (%) |  |  |  |  |  |  < 0.001a |
 married | 1001 (52.7) | 372 (59.4) | 233 (55.2) | 187 (48.1) | 209 (45.3) |  |
 widowed | 720 (37.9) | 197 (31.5) | 139 (32.9) | 165 (42.4) | 219 (47.5) |  |
 separated | 29 (1.5) | 11 (1.8) | 9 (2.1) | 6 (1.5) | 3 (0.7) |  |
 divorced | 32 (1.7) | 12 (1.9) | 9 (2.1) | 6 (1.5) | 5 (1.1) |  |
 single | 116 (6.1) | 34 (5.4) | 32 (7.6) | 25 (6.4) | 25 (5.4) |  |
Living with = others (%) | 1394 (75.1) | 453 (73.3) | 301 (74.3) | 286 (74.1) | 354 (79.0) | 0.166a |
Alcohol consumption (%) | Â | Â | Â | Â | Â | 0.013a |
 Never | 1013 (53.1) | 322 (51.1) | 216 (51.3) | 195 (49.5) | 280 (60.7) |  |
 ex-drinker | 103 (5.4) | 28 (4.4) | 25 (5.9) | 30 (7.6) | 20 (4.3) |  |
 drinker | 318 (16.7) | 117 (18.6) | 67 (15.9) | 73 (18.5) | 61 (13.2) |  |
 Social drinker | 472 (24.8) | 163 (25.9) | 113 (26.8) | 96 (24.4) | 100 (21.7) |  |
Collar1 = White (%) | 549 (38.2) | 215 (45.6) | 134 (43.5) | 96 (32.7) | 104 (28.7) |  < 0.001a |
P-ADL2 median [IQR] | 91.0 [68.0, 100.0] | 100.0 [89.0, 100.0] | 92.0 [77.2, 100.0] | 82.0 [53.0, 97.0] | 74.0 [39.5, 92.0] |  < 0.001c |
Specific P-ADL2: Personal hygiene (%) |  |  |  |  |  |  < 0.001a |
 0 | 135 (7.0) | 18 (2.8) | 16 (3.8) | 39 (9.8) | 62 (13.1) |  |
 1 | 102 (5.3) | 13 (2.0) | 14 (3.3) | 26 (6.5) | 49 (10.4) |  |
 3 | 229 (11.8) | 34 (5.3) | 28 (6.6) | 77 (19.2) | 90 (19.1) |  |
 4 | 277 (14.3) | 53 (8.3) | 72 (17.1) | 67 (16.8) | 85 (18.0) |  |
 5 | 1192 (61.6) | 523 (81.6) | 292 (69.2) | 191 (47.8) | 186 (39.4) |  |
Specific P-ADL2: Bathing (%) |  |  |  |  |  |  < 0.001a |
 0 | 211 (10.9) | 29 (4.5) | 36 (8.5) | 56 (14.0) | 90 (19.1) |  |
 1 | 128 (6.6) | 18 (2.8) | 15 (3.6) | 32 (8.0) | 63 (13.3) |  |
 3 | 288 (14.9) | 45 (7.0) | 51 (12.1) | 88 (22.0) | 104 (22.0) |  |
 4 | 318 (16.4) | 71 (11.1) | 92 (21.8) | 76 (19.0) | 79 (16.7) |  |
 5 | 990 (51.2) | 478 (74.6) | 228 (54.0) | 148 (37.0) | 136 (28.8) |  |
Specific P-ADL2: Feeding (%) |  |  |  |  |  |  < 0.001a |
 0 | 65 (3.4) | 17 (2.7) | 7 (1.7) | 20 (5.0) | 21 (4.4) |  |
 2 | 58 (3.0) | 6 (0.9) | 3 (0.7) | 16 (4.0) | 33 (7.0) |  |
 5 | 169 (8.7) | 19 (3.0) | 22 (5.2) | 49 (12.2) | 79 (16.7) |  |
 8 | 211 (10.9) | 34 (5.3) | 39 (9.2) | 61 (15.2) | 77 (16.3) |  |
 10 | 1432 (74.0) | 565 (88.1) | 351 (83.2) | 254 (63.5) | 262 (55.5) |  |
Specific P-ADL2: Toileting (%) |  |  |  |  |  |  < 0.001a |
 0 | 147 (7.6) | 18 (2.8) | 18 (4.3) | 42 (10.5) | 69 (14.6) |  |
 2 | 111 (5.7) | 20 (3.1) | 15 (3.6) | 32 (8.0) | 44 (9.3) |  |
 5 | 160 (8.3) | 16 (2.5) | 30 (7.1) | 45 (11.2) | 69 (14.6) |  |
 8 | 251 (13.0) | 59 (9.2) | 54 (12.8) | 60 (15.0) | 78 (16.5) |  |
 10 | 1266 (65.4) | 528 (82.4) | 305 (72.3) | 221 (55.2) | 212 (44.9) |  |
Specific P-ADL2: Stair Climbing (%) |  |  |  |  |  |  < 0.001a |
 0 | 328 (17.0) | 40 (6.2) | 60 (14.2) | 94 (23.5) | 134 (28.4) |  |
 2 | 150 (7.8) | 26 (4.1) | 28 (6.6) | 35 (8.8) | 61 (12.9) |  |
 5 | 317 (16.4) | 63 (9.8) | 70 (16.6) | 79 (19.8) | 105 (22.2) |  |
 8 | 351 (18.1) | 122 (19.0) | 83 (19.7) | 70 (17.5) | 76 (16.1) |  |
 10 | 789 (40.8) | 390 (60.8) | 181 (42.9) | 122 (30.5) | 96 (20.3) |  |
Specific P-ADL2: Dressing (%) |  |  |  |  |  |  < 0.001a |
 0 | 141 (7.3) | 20 (3.1) | 15 (3.6) | 41 (10.2) | 65 (13.8) |  |
 2 | 123 (6.4) | 14 (2.2) | 19 (4.5) | 34 (8.5) | 56 (11.9) |  |
 5 | 231 (11.9) | 33 (5.1) | 44 (10.4) | 60 (15.0) | 94 (19.9) |  |
 8 | 287 (14.8) | 61 (9.5) | 62 (14.7) | 77 (19.2) | 87 (18.4) |  |
 10 | 1153 (59.6) | 513 (80.0) | 282 (66.8) | 188 (47.0) | 170 (36.0) |  |
Specific P-ADL2: Bladder control (%) |  |  |  |  |  |  < 0.001a |
 0 | 152 (7.9) | 30 (4.7) | 15 (3.6) | 43 (10.8) | 64 (13.6) |  |
 2 | 87 (4.5) | 10 (1.6) | 11 (2.6) | 25 (6.2) | 41 (8.7) |  |
 5 | 174 (9.0) | 18 (2.8) | 32 (7.6) | 54 (13.5) | 70 (14.9) |  |
 8 | 285 (14.7) | 52 (8.1) | 61 (14.5) | 77 (19.2) | 95 (20.2) |  |
 10 | 1236 (63.9) | 531 (82.8) | 303 (71.8) | 201 (50.2) | 201 (42.7) |  |
Specific P-ADL2: Bowel control (%) |  |  |  |  |  |  < 0.001a |
 0 | 112 (5.8) | 19 (3.0) | 9 (2.1) | 34 (8.5) | 50 (10.6) |  |
 2 | 73 (3.8) | 11 (1.7) | 10 (2.4) | 20 (5.0) | 32 (6.8) |  |
 5 | 133 (6.9) | 17 (2.7) | 25 (5.9) | 39 (9.8) | 52 (11.0) |  |
 8 | 187 (9.7) | 26 (4.1) | 36 (8.5) | 58 (14.5) | 67 (14.2) |  |
 10 | 1430 (73.9) | 568 (88.6) | 342 (81.0) | 249 (62.3) | 271 (57.4) |  |
Specific P-ADL2: Ambulation (%) |  |  |  |  |  |  < 0.001a |
 0 | 146 (7.7) | 21 (3.3) | 21 (5.1) | 43 (10.9) | 61 (13.5) |  |
 3 | 135 (7.1) | 21 (3.3) | 23 (5.6) | 30 (7.6) | 61 (13.5) |  |
 8 | 285 (15.1) | 45 (7.1) | 62 (15.0) | 80 (20.4) | 98 (21.7) |  |
 12 | 452 (23.9) | 125 (19.7) | 96 (23.2) | 114 (29.0) | 117 (25.9) |  |
 15 | 874 (46.2) | 421 (66.5) | 212 (51.2) | 126 (32.1) | 115 (25.4) |  |
Specific P-ADL2: Wheelchair (%) |  |  |  |  |  |  < 0.001a |
 0 | 80 (44.2) | 20 (40.8) | 20 (51.3) | 17 (47.2) | 23 (40.4) |  |
 1 | 21 (11.6) | 2 (4.1) | 4 (10.3) | 4 (11.1) | 11 (19.3) |  |
 3 | 20 (11.0) | 1 (2.0) | 1 (2.6) | 8 (22.2) | 10 (17.5) |  |
 4 | 7 (3.9) | 1 (2.0) | 2 (5.1) | 3 (8.3) | 1 (1.8) |  |
 5 | 53 (29.3) | 25 (51.0) | 12 (30.8) | 4 (11.1) | 12 (21.1) |  |
Specific P-ADL2: Bed to chair transfer (%) |  |  |  |  |  |  < 0.001a |
 0 | 143 (7.4) | 19 (3.0) | 16 (3.8) | 36 (9.0) | 72 (15.3) |  |
 3 | 152 (7.9) | 28 (4.4) | 27 (6.4) | 38 (9.5) | 59 (12.5) |  |
 8 | 238 (12.3) | 33 (5.1) | 46 (10.9) | 72 (18.0) | 87 (18.4) |  |
 12 | 358 (18.5) | 90 (14.0) | 84 (19.9) | 89 (22.3) | 95 (20.1) |  |
 15 | 1043 (53.9) | 471 (73.5) | 249 (59.0) | 164 (41.1) | 159 (33.7) |  |
CIRS3 Illness Severity Index, median [IQR] | 1.7 [1.5, 1.9] | 1.6 [1.4, 1.8] | 1.7 [1.5, 1.9] | 1.7 [1.5, 1.9] | 1.7 [1.5, 2.0] |  < 0.001c |
CIRS3 Co-morbidity Index, median [IQR] | 3.0 [2.0, 4.0] | 3.0 [1.0, 4.0] | 3.0 [2.0, 4.0] | 3.0 [2.0, 4.0] | 3.0 [2.0, 5.0] |  < 0.001c |
Prescribed pharmaceuticals median [IQR] | 6.0 [4.0, 8.0] | 5.0 [3.0, 7.0] | 6.0 [4.0, 8.0] | 5.0 [3.0, 8.0] | 6.0 [4.0, 8.0] |  < 0.001c |
GDS4, median [IQR] | 1.0 [0.0, 2.0] | 0.0 [0.0, 1.0] | 2.0 [2.0, 3.0] | 1.0 [0.0, 1.0] | 2.0 [2.0, 3.0] |  < 0.001c |
SBT5, median [IQR] | 8.0 [3.8, 14.0] | 4.0 [0.0, 6.0] | 4.0 [2.0, 6.0] | 15.0 [12.0, 21.0] | 16.0 [12.0, 22.0] |  < 0.001c |
Cognitive impairment diagnosis = yes (%) | 879 (44.9) | 0 (0.0) | 0 (0.0) | 404 (100.0) | 475 (100.0) |  < 0.001a |
CIRS ICD for CI6,7, (%) | 165 (8.4) | 0 (0.0) | 0 (0.0) | 68 (16.8) | 97 (20.4) |  < 0.001a |
CIRS text, (%) | 162 (8.3) | 0 (0.0) | 0 (0.0) | 66 (16.3) | 96 (20.2) |  < 0.001a |
Pharmaceuticals ATC code for CI8, (%) | 20 (1.0) | 0 ( 0.0) | 0 ( 0.0) | 4 (1.0) | 16 ( 3.4) |  < 0.001b |
SBT ≥ 10, (%) | 860 (44.0) | 0 (0.0) | 0 (0.0) | 397 (98.3) | 463 (97.5) |  < 0.001a |
Depression diagnosis = yes (%) | 903 (46.2) | 0 (0.0) | 428 (100.0) | 0 ( 0.0) | 475 (100.0) |  < 0.001a |
CIRS ICD for depression9, (%) | 77 (3.9) | 0 (0.0) | 38 ( 8.9) | 0 ( 0.0) | 39 ( 8.2) |  < 0.001a |
CIRS text for depression, (%) | 205 (10.5) | 0 ( 0.0) | 104 (24.3) | 0 ( 0.0) | 101 (21.3) |  < 0.001a |
Pharmaceuticals ATC code for depression10, (%) | 331 (16.9) | 0 ( 0.0) | 147 (34.4) | 0 ( 0.0) | 184 (38.8) |  < 0.001a |
GDS ≥ 2, (%) | 706 (42.0) | 0 ( 0.0) | 340 (83.5) | 0 ( 0.0) | 366 (85.9) |  < 0.001a |
Death at 6 months = yes (%) | 484 (24.7) | 116 ( 17.9) | 97 ( 22.7) | 134 ( 33.2) | 137 ( 28.8) |  < 0.001a |
Days of follow up median [IQR] | 180.0 [180.0, 180.0] | 180.0 [180.0, 180.0] | 180.0 [180.0, 180.0] | 180.0 [91.0, 180.0] | 180.0 [115.0, 180.0] | 0.061 |